BRUKER CORP BRKR

Technology SIC 3826 - Laboratory Analytical Instruments NAICS Manufacturing › Computer and Electronic Product Manufacturing › Navigational, Measuring, Electromedical, and Control Instruments Manufacturing › Analytical Laboratory Instrument Manufacturing derived Nasdaq

We are a developer, manufacturer, and distributor of high-performance scientific instruments and analytical and diagnostic solutions that enable our customers to explore life and materials at microscopic, molecular and cellular levels. Many of our products are used to detect, measure and visualize structural characteristics of chemical, biological and industrial material samples. Our products and solutions address the rapidly evolving needs of a diverse array of customers in life and materials science research, biopharmaceuticals, applied markets, microbiology, in-vitro diagnostics, and nanotechnology. Our technology platforms include magnetic resonance, mass spectrometry, gas and liquid chromatography, X-ray, microscopy, metrology, and molecular spectroscopy technologies. We are enabling innovation, improved productivity, and customer success in post-genomic life science molecular and cell biology research and offer differentiated, high value life science and diagnostics systems and solutions in preclinical imaging, clinical phenomics research, proteomics and multiomics, spatial and single-cell biology, functional structural and condensate biology, as well as in clinical microbiology and molecular diagnostics. Our corporate headquarters are located in Billerica, Massachusetts. We maintain major technical and manufacturing centers in Europe and North America and have sales offices located throughout the world.

Last close 57.59 2026-10-23
Market cap $8.74B 2025-06-30 share count
52-week range 32.37 - 66.98

Valuation FY2025 figures against the last close

P/S2.5x
P/E—
P/FCF201.8x
EV/EBITDA35.7x
Dividend yield0.3%
Diluted EPS-0.15

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $3.44B$3.37B$2.96B$2.53B$2.42B$1.99B$2.07B$1.90B$1.77B$1.61B
Cost of revenue $1.86B$1.72B$1.45B$1.23B$1.21B$1.05B$1.08B$995.6M$949.9M$866.0M
Gross profit $1.58B$1.65B$1.51B$1.31B$1.21B$939.8M$995.3M$900.0M$816.0M$745.3M
R&D $395.2M$376.5M$294.8M$235.9M$220.8M$198.0M$187.7M$173.4M$161.6M$147.9M
SG&A $946.5M$893.8M$729.4M$607.4M$561.2M$468.6M$500.2M$444.7M$415.2M$389.8M
Total operating expenses $1.51B$1.40B$1.08B$873.0M$796.3M$691.5M$694.4M$637.6M$596.5M$563.5M
Operating income $68.2M$253.1M$436.9M$432.7M$413.3M$248.3M$300.9M$262.4M$219.5M$181.8M
Interest expense $60.3M$47.9M$16.4M$16.1M$14.3M$14.4M$16.0M$12.6M$15.4M$13.2M
Pre-tax income $22.0M$206.9M$544.2M$413.9M$393.6M$225.8M$280.4M$244.7M$197.8M$177.6M
Income tax $29.3M$91.4M$117.7M$116.4M$113.0M$64.4M$82.4M$63.7M$117.5M$23.1M
Net income -$8.3M$113.8M$428.5M$298.5M$280.6M$157.8M$197.2M$179.7M$78.6M$153.6M
EPS, basic -0.150.762.922.001.831.031.271.150.500.95
EPS, diluted -0.150.762.901.991.811.021.261.140.490.95
Shares, diluted (wtd. avg.) 151.8M149.5M147.2M149153155157157.2M159.1M162.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $298.8M$183.4M$491.6M$648.7M$1.07B$685.5M$681.9M$326.3M$328.9M$345.9M
Short-term investments ———$0$100.0M$50.0M$6.6M$0$114.2M—
Receivables $544.9M$565.5M$492.0M$472.7M$416.9M$335.3M$362.2M$357.2M$319.3M$243.9M
Inventory $1.09B$1.07B$968.3M$800.1M$710.1M$692.3M$577.2M$509.6M$486.2M$440.4M
Total current assets $2.21B$2.05B$2.16B$2.11B$2.47B$1.93B$1.80B$1.30B$1.36B$1.28B
Property, plant and equipment $744.8M$669.3M$599.7M$487.0M$406.1M$395.5M$306.1M$270.6M$266.5M$239.1M
Goodwill $1.55B$1.51B$582.6M$457.6M$339.5M$320.4M$293.0M$275.7M$169.8M$130.6M
Other intangibles $899.6M$912.5M$330.5M$270.9M$211.8M$229.1M$233.2M$218.7M$82.4M$69.7M
Total assets $6.24B$5.81B$4.25B$3.61B$3.65B$3.05B$2.77B$2.13B$1.95B$1.81B
Accounts payable $215.9M$234.1M$202.7M$178.4M$147.4M$134.6M$118.4M$104.5M$90.8M$86.1M
Total current liabilities $1.28B$1.28B$1.20B$914.3M$938.5M$791.9M$645.6M$599.3M$524.5M$524.7M
Long-term debt $1.85B$2.06B$1.16B$1.20B$1.22B$842.3M$812.8M$322.6M——
Total liabilities $3.73B$3.99B$2.84B$2.48B——————
Retained earnings $2.36B$2.41B$2.32B$1.93B$1.66B$1.41B$1.27B$1.10B$942.0M$885.2M
Total equity $2.46B$1.78B$1.39B$1.13B$1.08B$974.3M$917.1M$905.1M$733.5M$693.1M

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $134.1M$251.3M$350.1M$274.4M$282.4M$332.2M$213.4M$239.7M$154.4M$130.8M
Depreciation and amortisation $220.3M$183.8M$114.9M$88.8M$89.1M$80.4M$75.6M$64.9M$63.9M$54.3M
Stock-based compensation $20.2M$25.3M$30.9M$27.7M$17.2M$16.0M$9.6M$11.3M$11.0M$9.4M
Capital expenditure $90.8M$115.3M$106.9M$129.2M$92.0M$97.2M$12.3M$49.2M$43.7M$37.1M
Investing cash flow -$196.5M-$1.76B-$326.0M-$251.6M-$192.4M-$192.7M-$158.4M-$123.4M-$30.2M-$21.8M
Financing cash flow $135.1M$1.23B-$193.4M-$415.3M$318.7M-$161.6M$300.0M-$112.4M-$159.0M-$27.9M
Dividends paid $22.8M$30.2M$29.4M$29.8M$24.2M$24.6M$25.0M$25.1M$25.4M$25.8M
Buybacks $10.0M$0$152.3M$263.1M$153.3M$123.2M$142.3M$200.0K$152.2M$160.0M

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-151305.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -1B 0 1B 2B 3B 4B Revenue, FY2016: 1.6B Gross profit, FY2016: 745.3M Net income, FY2016: 153.6M Revenue, FY2017: 1.8B Gross profit, FY2017: 816M Net income, FY2017: 78.6M Revenue, FY2018: 1.9B Gross profit, FY2018: 900M Net income, FY2018: 179.7M Revenue, FY2019: 2.1B Gross profit, FY2019: 995.3M Net income, FY2019: 197.2M Revenue, FY2020: 2B Gross profit, FY2020: 939.8M Net income, FY2020: 157.8M Revenue, FY2021: 2.4B Gross profit, FY2021: 1.2B Net income, FY2021: 280.6M Revenue, FY2022: 2.5B Gross profit, FY2022: 1.3B Net income, FY2022: 298.5M Revenue, FY2023: 3B Gross profit, FY2023: 1.5B Net income, FY2023: 428.5M Revenue, FY2024: 3.4B Gross profit, FY2024: 1.6B Net income, FY2024: 113.8M Revenue, FY2025: 3.4B Gross profit, FY2025: 1.6B Net income, FY2025: -8.3M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $1.61B $1.77B $1.90B $2.07B $1.99B $2.42B $2.53B $2.96B $3.37B $3.44B
Gross profit $745.3M $816.0M $900.0M $995.3M $939.8M $1.21B $1.31B $1.51B $1.65B $1.58B
Net income $153.6M $78.6M $179.7M $197.2M $157.8M $280.6M $298.5M $428.5M $113.8M -$8.3M

Recent filings and events

  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Other event Item 8.01
  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Shareholder vote Item 5.07
  • Other event Item 8.01
  • Results announced Item 2.02
  • Other event Item 8.01
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Officer or director change Item 5.02
  • Annual report filed A new 10-K. The figures and the business description on this site come from it. Form 10-K
  • Officer or director change Item 5.02

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 3826

TickerCompanyMarket capP/ERevenue growth
A AGILENT TECHNOLOGIES, INC. $48.79B 37.9x 6.7%
WAT WATERS CORP /DE/ $44.57B 42.2x 7.0%
ILMN ILLUMINA, INC. $40.68B 49.4x -0.7%
MTD METTLER TOLEDO INTERNATIONAL INC/ $33.47B 39.7x 4.0%
RVTY REVVITY, INC. $17.72B 76.7x 3.7%
AVTR Avantor, Inc. $11.80B — -3.4%
BIO BIO-RAD LABORATORIES, INC. $9.89B 13.3x 0.7%
TXG 10x Genomics, Inc. $9.30B — 5.2%